These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3583393)

  • 1. Drug design: nitrosoureas.
    Eisenbrand G; Müller N; Schreiber J; Stahl W; Sterzel W; Berger MR; Zeller WJ; Fiebig H
    IARC Sci Publ; 1986; (78):281-94. PubMed ID: 3583393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities.
    Eisenbrand G
    IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas.
    Stahl W; Krauth-Siegel RL; Schirmer RH; Eisenbrand G
    IARC Sci Publ; 1987; (84):191-3. PubMed ID: 2960614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage and repair in the bone marrow of rats treated with four chloroethylnitrosoureas.
    Bedford P; Eisenbrand G
    Cancer Res; 1984 Feb; 44(2):514-8. PubMed ID: 6229329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of newly synthesized 2-chloroethyl-nitrosoureas on rat leukemia L 5222.
    Zeller WJ; Eisenbrand G
    Oncology; 1981; 38(1):39-42. PubMed ID: 7443175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cell cycle position on the survival of 9L cells treated with nitrosoureas that alkylate, cross-link, and carbamoylate.
    Linfoot PA; Gray JW; Dean PN; Marton LJ; Deen DF
    Cancer Res; 1986 May; 46(5):2402-6. PubMed ID: 3697983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activity of hydroxylated chloroethylnitrosoureas.
    Zeller WJ; Frühauf S; Chen G; Eisenbrand G; Lijinsky W
    Cancer Res; 1989 Jun; 49(12):3267-70. PubMed ID: 2720679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapeutic characterization of new nitrosourea compounds].
    Zeller WJ; Berger MR; Eisenbrand G; Petru E
    Arch Geschwulstforsch; 1988; 58(3):137-49. PubMed ID: 3415433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of more selective anti-cancer nitrosoureas.
    Eisenbrand G; Berger MR; Fischer J; Schneider MR; Tang W; Zeller WJ
    Anticancer Drug Des; 1988 Mar; 2(4):351-9. PubMed ID: 3365304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of newly synthesized 2-chloroethylnitrosoureas in preterminal leukemia L 5222 and in two transplanted neurogenic tumors.
    Berger M; Zeller WJ; Eisenbrand G; Lin PZ; Nakra M; Schmähl D
    Arzneimittelforschung; 1982; 32(5):481-4. PubMed ID: 6285938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reaction of N-(2-chloroethyl)-N-nitrosoureas with DNA: effect of buffers on DNA adduction, cross-linking, and cytotoxicity.
    Chen FX; Bodell WJ; Liang G; Gold B
    Chem Res Toxicol; 1996; 9(1):208-14. PubMed ID: 8924592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cancer chemotherapy with special reference to pharmacokinetics of nitrosoureas].
    Wakui A
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1327-38. PubMed ID: 6223595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-consistent-field comparative studies of some nitrosoureas and nitrosamides.
    Sapse AM; Snyder G; Osorio L
    Cancer Res; 1984 May; 44(5):1904-7. PubMed ID: 6713391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma PANO2.
    Papageorgiou A; Lialiaris T; Stergiou E; Stergiou I; Tsigris C; Kourti A; Geromichalos G; Stravoravdi P; Trafalis D; Athanassiou AE; Pitsas A; Camoutsis Ch
    J BUON; 2008; 13(2):235-9. PubMed ID: 18555471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of new estrogen-linked 2-chloroethylnitrosoureas. I. Short term anticancer efficacy in methylnitrosourea-induced rat mammary carcinoma and hormonal activity in mice.
    Berger MR; Floride J; Schreiber J; Schmähl D; Eisenbrand G
    J Cancer Res Clin Oncol; 1984; 108(1):148-53. PubMed ID: 6746705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkylation of 2'-deoxythymidylyl(3'----5')-2'-deoxythymidine with 2-hydroxyethylnitrosourea and stability of the resulting phosphotriester.
    Müller N; Conrad J; Eisenbrand G
    IARC Sci Publ; 1987; (84):194-6. PubMed ID: 2445673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of the chloroethylnitrosoureas.
    Lemoine A; Lucas C; Ings RM
    Xenobiotica; 1991 Jun; 21(6):775-91. PubMed ID: 1949908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoside analogs. 14. The synthesis of antitumor activity in mice of molecular combinations of 5-fluorouracil and N-(2-Chloroethyl)-N-nitrosourea moieties separated by a three-carbon chain.
    McElhinney RS; McCormick JE; Bibby MC; Double JA; Radacic M; Dumont P
    J Med Chem; 1996 Mar; 39(7):1403-12. PubMed ID: 8691470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas.
    Bodell WJ; Gerosa M; Aida T; Berger MS; Rosenblum ML
    Cancer Res; 1985 Aug; 45(8):3460-4. PubMed ID: 3860285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and study of the anti-leukaemic activity of N,N'-substituted amidines and bis-amidines.
    Dumont P; Fuks R; Atassi G; Hanocq M
    J Pharm Belg; 1985; 40(6):373-86. PubMed ID: 3831292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.